Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction
Lin Liu, Fan Wang, Yu Tong, Lin-Feng Li, Yanfeng Liu, Wei-Qiang Gao
Journal：CELL PROLIFERATION
IF：5.04
DOI：10.1111/cpr.12718
PMID：
Published：2019-11-13
research field：肿瘤学分子生物学药理学
Abstract
We investigated the anti‐cancer activity of pentamidine, an anti‐protozoal cationic aromatic diamidine drug, in prostate cancer cells and aimed to provide valuable insights for improving the efficacy of prostate cancer treatment.
本文使用的Yeasen产品
相关产品
推荐应用
